PHC GROUPPHC Holdings Corporation

The PHC Group’s
Response to



We deeply express our condolences to victims of COVID-19 infection and wish those who have been infected a quick recovery. We would also like to extend our sincere gratitude to all healthcare professionals who work on the forefront to treat patients and everyone involved in supporting our living infrastructure.

The PHC Group is committed to taking the best measures to prevent infections internally and externally, while prioritizing the safety and health of all stakeholders including healthcare professionals, researchers, patients, and employees. At the same time, all PHC Group companies are collectively taking various initiatives to expand the products and services essential to our customers and patients and to ensure a stable supply of them.

Products and Services Committed to Support Customers in Healthcare and Research


Preservation Equipment, Incubators, Experiment Systems, and Laboratory Autoclaves

PHCbi supports healthcare professionals and researchers by offering various equipment including ultra-low temperature freezers for preserving specimen from COVID-19 patients, pharmaceutical refrigerators and CO2 incubators for developing COVID-19 medicines and vaccines.

Solutions for COVID-19 vaccine storage
Link to related product
Efforts of the Biomedical Business Unit (YouTube):
“PHCbi Supporting the Fight Against COVID-19" (Japanese)
Head of Biomedical Business Unit, PHC Corporation
Nobuaki Nakamura *Video recorded in summer 2021

Digital Diabetes Solutions

The digital diabetes solutions provided by Ascensia Diabetes Care help people with diabetes make the most of remote consultations for their diabetes. The CONTOUR®DIABETES app links to their blood glucose monitoring system to enable them to share their blood glucose data more easily with their healthcare professionals. The Ascensia team has also been using webinars and virtual trainings to ensure healthcare professionals and people with diabetes continue to get the information they need.


Testing Services

LSI Medience Corporation has been providing COVID-19 PCR testing service since February 2020. The company is working to prepare and expand testing equipment to respond to the increase in order requests.
From December 21, 2020, PCR testing that can simultaneously detect SARS-CoV-2 and influenza nucleic acid is offered to check combined infections of flu and COVID-19.

The Response at PHC Group Companies

Ascensia Diabetes Care Holdings AG

Epredia Holdings Ltd.
COVID-19 Update from Epredia

Share this page

Twitter Facebook LinkedIn